TOP STORIES

• BUSINESS Pfizer’s ALK Inhibitor Lorbrena, Shire’s HAE Drug Now Available in Japan
  November 21, 2018

• BUSINESS Mitsubishi Tanabe Cuts FY2020 Targets in 5-Year Biz Plan on Flagging Royalty, Development Delay
  November 21, 2018

• BUSINESS 3 Japan Generic Majors Log 6% Growth in Combined April-September Sales despite Price Revision
  November 20, 2018

• BUSINESS 4 Major Wholesalers See 46.1% Increase in 1st Half Operating Profit due to Reductions in Yakkasa and SGA Costs
  November 19, 2018

• BUSINESS AstraZeneca Japan Set to Roll Out 4 New Treatments Every Year through 2021: Chief
  November 16, 2018

• REGULATORY Keytruda’s MSI-H Cancer Use Up for MHLW Panel Review Nov. 29; Wider Hemlibra Indication, 1st Line Tecentriq Also on Agenda
  November 16, 2018

• BUSINESS Hib Vaccine Wind-Up, Development Flop Trigger GSK, Daiichi Sankyo to Shutter JV
  November 15, 2018

• REGULATORY Chuikyo Agrees on October 2019 Drug Price Revision for Tax Hike, but Final Call Is Up to Govt
  November 15, 2018

• REGULATORY Maviret Faces 25% Price Slash in Quarterly Review
  November 14, 2018

• BUSINESS GSK, Daiichi Sankyo Dissolve Vaccine JV
  November 14, 2018

• REGULATORY Novartis’ SMA Gene Therapy Filed in Japan on Nov. 1 after US, EU; What Will Happen to Sakigake Status?
  November 13, 2018

• BUSINESS Big Takeda Could Debut as Early as January 8, De-facto Vote on Shire Deal Set for Dec. 5
  November 13, 2018

• BUSINESS Takeda: De-facto Vote on Shire Deal Set for Dec. 5
  November 12, 2018

• BUSINESS Japan Is Top Strategic Market for Biogen: CEO
  November 12, 2018

• ORGANIZATION 7 EFPIA Companies Revised R&D Strategies after April Pricing Overhaul: Survey
  November 9, 2018

• REGULATORY LDP Health Bigwigs Agree to Push for October 2019 Revision
  November 9, 2018

• REGULATORY MHLW Pitches “Tiered Model” for CEA Price Tweak, but Faces Chuikyo Opposition
  November 8, 2018

• REGULATORY FY2019 Tax Reform Debate Going into Full Swing; Will Pharma Industry Win Expansion in R&D Credit?
  November 7, 2018

• ORGANIZATION Wrong Policies Could Drive Investments Out of Japan amid China’s Rise, PhRMA Int’l Advocacy Chief Warns
  November 6, 2018

• BUSINESS Balancing Act: All Eyes on Nesp Biosame Pricing before June 2019 Listing, Biosimilars to Follow in November
  November 5, 2018

ページ

• « 先頭
• ‹ Prev
• …
• 132
• 133
• 134
• 135
• 136
• 137
• 138
• 139
• 140
• …
• Next ›
• 最終 »